CEO Brian Lian highlighted the company's progress ... aiming to broaden the company's obesity treatment pipeline. Asim Rana, Truist Securities: Asked about the timing of Phase 2 oral readout ...

Fintel reports that on October 5, 2023, Truist Securities maintained coverage of Five Below (NASDAQ:FIVE) with a Buy recommendation. As of October 5, 2023, the average one-year price target for ...

ATLANTA, March 25, 2025 /PRNewswire/ -- Truist Securities announced today that Danielle Brill has joined the firm as managing director, strengthening its equity research coverage in the ...

Brian Boudreaux, a Truist spokesperson, confirmed to CBJ. Truist did not comment on the headcount reduction. “Truist Securities regularly assesses opportunities for our organization and makes ...

Truist Securities has decided to maintain its Buy rating of Immunogen (NASDAQ:IMGN) and raise its price target from $15.00 to $18.00. Shares of Immunogen are trading down 2.6% over the last 24 ...